Sutro Biopharma (STRO) Change in Account Payables (2017 - 2025)
Sutro Biopharma (STRO) reported Change in Account Payables of $575000.0 for Q4 2025, down 86.05% on a YoY basis from $4.1 million in Q4 2024, and down 78.57% sequentially from $2.7 million in Q3 2025.
Sutro Biopharma (STRO) Change in Account Payables (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Change in Account Payables data on file, last reported at $575000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 86.05% year-over-year to $575000.0; the trailing twelve-month figure through Dec 2025 stood at -$2.5 million (down 449.58% YoY), and the FY2025 full-year result was -$2.5 million, down 449.58% from the prior year.
- Change in Account Payables slipped to $575000.0 in Q4 2025, from $2.7 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.1 million in Q4 2024 to a low of -$3.8 million in Q2 2025.
- A 5-year average of $226650.0 and a median of -$292500.0 in 2021 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 1058.08% in 2024 and soared 2281.3% in 2025, its largest moves.
- Tracing STRO's Change in Account Payables over 5 years: stood at -$1.8 million in 2021, then surged by 47.24% to -$937000.0 in 2022, then surged by 532.98% to $4.1 million in 2023, then advanced by 1.58% to $4.1 million in 2024, then sank by 86.05% to $575000.0 in 2025.
- Business Quant data shows STRO's Change in Account Payables at $575000.0 in Q4 2025, $2.7 million in Q3 2025, and -$3.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | 575,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 575,000.00 |
| Dec 31, 2025 | 575,000.00 |
| Sep 30, 2025 | 2.68 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | -3.85 Mn |
| Jun 30, 2025 | -3.85 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | -123,000.00 |
| Sep 30, 2024 | -123,000.00 |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Sep 30, 2023 | 1.41 Mn |